Searched for
GENERIC PARTNERS HOLDINGS
Flex office: As GCCs boom, Table Space is betting big on managed workspacesAs India’s GCC ecosystem expands rapidly, enterprise managed workspace providers are emerging as critical enablers of global firms entering...- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
- Two separate venues for pharma industry expos in Delhi-NCRCPHI India and PMEC India are expanding their pharmaceutical expos to two venues in Delhi-NCR. This move aims to support the rapid growth o...
- AI-armed founders disrupting venture capitalism?Indian venture capitalists hold billions, but the traditional funding model faces disruption. Founders now build and scale businesses with ...
- Natco Pharma launches generic drug with 180-day exclusivity in USNatco Pharma has launched Bosentan tablets, a generic version of Tracleer, in the US for treating pulmonary arterial hypertension in young ...
- Why NMC's mandate for stopping branded generic prescriptions was uncalled forBranded generics also add significant value to the healthcare ecosystem. They develop and circulate patient education materials. In-patient...
- Amazon, Cartier sue counterfeiters for selling fake luxury goods on InstagramAmazon has invested more than $900 million and employed more than 12,000 people dedicated to protecting customers and brands.
- Boehringer Ingelheim obtains interim injunction against four Indian drug cos from selling its diabetes drugBI said the injunctions restrain the domestic pharma companies from infringing the patent of Linagliptin by advertising, launching, making,...
- Pharma companies bag 40% of US genericsA steady increase in drug approvals and portfolio rationalisation by MNCs resulted in India’s volume share rising by 5% over the last few m...
- Strides Shasun completes acquisition of Generic PartnersThe Bengaluru-based firm had inked a pact to acquire 51 per cent stake in Australia's Generic Partners Holdings Co for AUD 15 million and a...
- Strides Shashun slides after announcing two acquisitionsShares of Strides Shashun dropped over 2 per cent in Tuesday's trade after the drugmaker said it had acquired controlling stakes in Kenya's...
- Drug firm Strides acquires controlling stakes in Kenyan, Australian cosDrug firm Strides Shasun has acquired controlling stakes in Kenya's Universal Corporation and Australia-based Generic Partners Holdings.
- Natco settles patent suit with Gilead, others over TamifluNatco Pharma and its partner Alvogen today said they have settled patent infringement suit with Gilead Sciences Inc and others over Tamiflu.
- Japan’s Meiji Holdings acquires Medreich for Rs 1,720 crore“The Meiji Group wants to enter the global generics field, particularly in Asia and emerging countries,” said the company press release.
- Emcure Pharmaceuticals plans to raise Rs 600 crore via IPOEmcure Pharmaceuticals has a pan India marketing and distribution presence with a field force of more than 4,800 personnel, as of March 31,...
- Fujifilm, Dr Reddy’s call off Japanese JV pactDr. Reddy's Laboratories and Japan's Fujifilm Corp have decided to terminate joint venture partnership they entered into in July 2011.
- Pfizer scraps Insulin pact with BioconPfizer Inc has terminated a deal to sell Biocon's insulin products globally, dealing the Indian company a blow and calling into question si...
- Indian cos eye $4bn generic opportunityExperts feel that after allowing 90% price erosion once generic drug versions appear in the market, and due to intense competition, the act...
- GSK enters JV for generics pushUK-based GSK on Thursday entered into an alliance with South African generic firm Aspen Pharma to sell the latter’s generic drugs in severa...
- Windfall for cos eyeing US oncology marketWith anti-cancer blockbuster drugs set to go off-patent in the US in the next three to four years, generic players are gearing up to tap th...
Load More
